Surescripts Named Qualified Health Information Network Surescripts Health Information Network LLC™, a subsidiary of Surescripts®, has officially been designated as a Qualified Health Information Network® (QHIN™) by The Sequoia Project, Inc., the Recognized Coordinating Entity® (RCE®) overseeing implementation of the…
ZAP Surgical to Unveil ZAP-X® Radiosurgery Platform at ESTRO 2025 ZAP Surgical Systems, Inc., a global leader in non-invasive brain surgery technology, has announced its first-time participation at the 2025 ESTRO (European Society for Radiotherapy and Oncology) annual scientific meeting,…
ABEC Unveils Breakthrough Single-Use Bioreactor for Cell Therapy ABEC, a global leader in engineering and manufacturing solutions for the biotechnology industry, has announced the launch of its Advanced Therapy Bioreactor (ATB™)—a next-generation system that represents a major breakthrough in cell…
QIAGEN to Launch 3 New Sample Prep Instruments by 2026 for Lab Automation QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) has announced plans to launch three new sample preparation instruments in 2025 and 2026. This move is part of…
Bruno Vision Care Gets FDA Approval for Deseyne® Contact Lens with FusionTechnology™ Bruno Vision Care LLC, an innovative leader in eye care technology, has achieved a major milestone with the FDA’s approval of its Deseyne® (vifilcon C) daily disposable contact…
Aptar: iPUMP® Boosts Adherence to SLIT Allergy Treatment Aptar Digital Health, a leader in digital health solutions, is pleased to announce the positive results from the SPEED1 survey, which demonstrate the effectiveness of the iPUMP® connected assistant in enhancing patient…
ATED Therapeutics Develops Simple Blood Test for Parkinson’s ATED Therapeutics Ltd. has announced the development of a new, rapid diagnostic test for Parkinson’s disease. Created in collaboration with researchers at the Hebrew University of Jerusalem, the test uses a novel…
JAMA Study Confirms Oncotype DX Test Reliability Across Races and Ethnicities Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer screening and diagnostics, announced the publication of a comprehensive review in JAMA Oncology that reinforces the reliability and predictive power…
Edwards SAPIEN M3 Gets CE Mark as First Transfemoral TMVR System Edwards Lifesciences Corporation (NYSE: EW) has announced that its groundbreaking SAPIEN M3 mitral valve replacement system has received CE Mark approval, making it the world’s first transfemoral transcatheter mitral…
Nuclera Boosts eProtein Discovery for Membrane Protein Production Nuclera, a biotechnology company revolutionizing protein expression and optimization, has announced a major enhancement to its eProtein Discovery™ system: a new workflow designed specifically for membrane protein production. This added functionality allows…
AdvanCell Secures $18M MRFF Grant for Prostate Cancer Therapy AdvanCell, a clinical-stage radiopharmaceutical company pioneering next-generation cancer therapeutics, has been awarded $18 million in funding from the Australian Federal Government through the Medical Research Future Fund (MRFF) Frontiers Initiative. This…
RHÖN-KLINIKUM Campus Bad Neustadt Opens New Geriatric Traumatology and Orthogeriatrics Unit The RHÖN-KLINIKUM Campus Bad Neustadt has inaugurated a new specialized treatment unit dedicated to geriatric traumatology and orthogeriatrics. Designed to provide holistic, patient-centered care, this unit caters specifically to…